Mostrando 3 resultados de: 3
Filtros aplicados
Origen
scopus(3)
Inhibitors of lipogenic enzymes as a potential therapy against cancer
ReviewAbstract: Cancer cells rely on several metabolic pathways such as lipid metabolism to meet the increase in enePalabras claves:cancer drugs, lipid metabolism, lipogenic enzyme inhibitorsAutores:Ariza X., Herrero L., Makowski K., Marta López, Nicolás MontesdeocaFuentes:scopusSynthesis of new carnitine palmitoyltransferase I inhibitors derivatives of C75
ArticleAbstract: Carnitine Palmitoyltransferase (CPT1) is an enzyme that catalyzes the transport of fatty acids fromPalabras claves:C75, Carnitine palmitoyltransferase 1 inhibitor, CPT1, α-Methylene-γ-butyrolactonesAutores:Alicia Venegas, Ariza J., Garcia J., Herrero L., Makowski K., Marta López, Mera P., Serra D.Fuentes:scopusTargeting energy expenditure—drugs for obesity treatment
ReviewAbstract: Obesity and overweight are associated with lethal diseases. In this context, obese and overweight inPalabras claves:clinical trials, energy expenditure, Energy metabolism, FDA-approved, obesity, Thermogenesis, Treatments under development, Withdrawn treatmentsAutores:Alberício F., Carlos M. Jimenez-Muñoz, Makowski K., Marta LópezFuentes:scopus